Skip to main content

Urine Trouble: What drug screening in the clinical laboratory can and can't tell us

From the 2021 Joint Annual Meeting (recorded 6/29/2021)
Presented by Stephanie Noblit, Esq., MLS (ASCP)CM

Drug screens are a routine test in the clinical laboratory, but they are also an important part of monitoring the opioid crisis in America. When performing drug screens, it is important to think about the bigger picture and the narrative the results are telling you (or failing to tell you) about your community.

At the conclusion of this presentation, participants will be able to:

  • Summarize the phases of the opioid epidemic.
  • Identify the pitfalls of drugs screens within the average clinical laboratory.
  • Explain the purpose of programs such as the Drug Enforcement Administration's Toxicology Testing Program.

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General (Chemistry) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.